Dechra Pharmaceuticals

Expected Changes in Clinical Signs of Hyperadrenocorticism

First recheck at 2 weeks*

  • Owners should have noticed that the dog is drinking less and urinating less
  • The ravenous appetite and excessive panting should have decreased
  • Lethargy is another clinical sign of Cushing’s syndrome that rapidly responds to treatment; even at the first 14-day check many owners have noticed their dogs are more active

Re-examination at 12 weeks*

  • At day 84 after starting treatment with VETORYL Capsules, 80% of dogs were considered treatment successes
  • At day 84, the percentage of dogs showing improvements in activity, appetite, thirst, urination, and panting ranged from 81% to 93%
  • In 93% of dogs, improvement in clinical assessments were noted at day 84

*Data on file at Dechra Veterinary Products: US Field Study

  • Vetoryl
  • FDA Compounding Letter 
  • Vetoryl Client Brochure 
  • Vetoryl Technical Brochure
  • Vetoryl Technical Brochure 
Country
Search
  • Global
  • Denmark
  • Finland
  • France
  • Germany
  • Netherlands
  • Ireland
  • Norway
  • Spain
  • Sweden
  • United Kingdom
  • USA
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Global
  • Holland
  • Ireland
  • Norway
  • Spain
  • Sweden
  • UK
  • USA

Search
Search